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Background: The objective of this study is to characterize the association between metabolic syn-
drome (MetS) and periodontitis in women, for which there is limited evidence.
Methods: Cross-sectional associations between MetS and periodontitis were examined in 657 post-
menopausal women aged 50 to 79 years enrolled in a periodontal disease study ancillary to the Women’s
Health Initiative Observational Study. Whole-mouth measures of alveolar crest height (ACH), clinical
attachment level (CAL), probing depth (PD), gingival bleeding, and supragingival plaque and mea-
sures to define MetS using National Cholesterol Education Program criteria were from a clinical exam-
ination. Study outcomes were defined as: 1) mean ACH ‡3 mm, two sites ‡5 mm, or tooth loss to
periodontitis; 2) ‡2 sites with CAL ‡6 mm and ‡1 site with PD ‡5 mm; 3) gingival bleeding at ‡50%
of sites; and 4) supragingival plaque at ‡50% of sites. Logistic regression was used to estimate odds
ratios (ORs) and 95% confidence intervals (CIs).
Results: In unadjusted analyses, MetS (prevalence: 25.6%) was significantly associated with supragin-
gival plaque (OR = 1.74; 95% CI: 1.22 to 2.50) and non-significantly associated with periodontitis de-
fined by ACH (OR = 1.23; 95% CI: 0.81 to 1.85) and gingival bleeding (OR = 1.20; 95% CI: 0.81 to
1.77). Adjustment for age, smoking, and other confounders attenuated observed associations, though
supragingival plaque remained significant (OR = 1.47; 95% CI: 1.00 to 2.16; P = 0.049). MetS was not
associated with periodontitis defined by CAL and PD.
Conclusions: A consistent association between MetS and measures of periodontitis was not seen in
this cohort of postmenopausal women. An association between MetS and supragingival plaque requires
further investigation. J Periodontol 2014;85:1489-1501.
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P
eriodontal disease is a common, preventable dis-
ease with increasing public health implications
among older adults.1,2 Recent findings indicate
that 64% of U.S. adults 65 years and older have mod-
erate to severe periodontal disease.3 Periodontal dis-
ease is associated with impaired dietary intake4 and
quality of life5 and higher risk of diabetes6 and car-
diovascular mortality7 in older adults. Established
periodontal risk factors include smoking, poorly
controlled diabetes, and poor oral hygiene.8 Iden-
tifying other modifiable risk factors is a priority to
improve population control of periodontal disease
and its clinical complications.1,2,8
Metabolic syndrome (MetS) is a condition of co-
existing factors including elevated blood pressure,
dyslipidemia, hyperglycemia, and obesity that more
than doubles the relative risks of diabetes and athe-
rothrombosis.9,10 MetS afflicts 55% of U.S. women 60
years and older11 likely owing to estrogen deficiency–
induced abdominal fat accretion and hepatic lipase
upregulation common with menopause.12 MetS is
a putative factor for modified host immune response
and acceleration of periodontitis.13 Studies suggest
that MetS could be adversely associated with peri-
odontal disease.14-24 No study has focused on older
postmenopausal women, who may be particularly
susceptible to both conditions. The aim of the present
study is to examine cross-sectional associations be-
tween MetS and several measures of periodontal




Participants were enrolled in the Buffalo Osteoporosis
and Periodontal Disease (OsteoPerio) Study,25-27 a
prospective cohort study on osteoporosis and peri-
odontal disease ancillary to the Women’s Health Ini-
tiative Observational Study (WHI-OS).28 Participants
were recruited from 2,249 women aged 50 to 79
years enrolled in the parent WHI-OS during 1993 to
1998 at the Buffalo, New York, clinical center. Baseline
assessments in the OsteoPerio study were con-
ducted during 1997 to 2001 and formed the basis
for the present study. Eligibility for the OsteoPerio
study included: 1) at least six teeth; 2) no bilateral
hip replacement; 3) no history of bone disease
other than osteoporosis; and 4) no history of cancer
in the past 10 years. Of the 1,341 women who com-
pleted baseline periodontal assessments, a venous
blood sample was available in a subset of 657 women
(aged 65.5 – 6.6 years). Blood samples were avail-
able only in a subset of the study cohort because blood
collection was not implemented until about a third
of participants had completed study visits. Women
with and without blood samples were compared,
and there do not appear to be systematic differences
in key demographic or clinical factors. Written con-
sent was provided for all aspects of the WHI-OS and
OsteoPerio studies, which were approved by the
University at Buffalo Institutional Review Board.
Oral Examinations
Calibrated dental examiners performed whole-mouth
oral examinations using procedures guided by na-
tional standards29 as previously described.25-27 The
sequence of the periodontal measures was the same
for all participants; the vast majority (>90%) were
completed during morning hours. Clinical probing
methods were used to assess probing depth (PD),
clinical attachment level (CAL), and gingival bleed-
ing. PD was defined as the distance in millimeters
from the gingival margin to the base of the gingival
sulcus measured using a constant-force electronic
probe30 on six sites per tooth in all teeth except for
third molars. Among a subset of 724 women in the
OsteoPerio study, within-examiner coefficient of var-
iation and intraclass correlation were 6% and 0.91
for replicate measures. A manual probe was used to
measure the distance from the cemento-enamel junc-
tion (CEJ) to the gingival margin at the same six
sites per tooth, and CAL was calculated by sub-
tracting this distance from PD. Values for inter-
proximal surfaces were used to calculate worst-site
and composite whole-mouth mean PD and CAL.
Extent and severity were also calculated for CAL
and PD,25 with extent defined as the percent of
interproximal sites reaching ‡4 mm and severity
defined as the mean value across those sites. Gin-
gival bleeding on swiping (absent or present) was
assessed at three sites per tooth using the manual
probe inserted 2 mm into the gingival sulcus par-
allel to the long axis of tooth, moving in a horizontal
direction, and defined as the percentage of sites
bleeding in the whole mouth. Supragingival plaque
(absent or present) was assessed by inspection at
the same three sites per tooth and defined as the
percentage of sites with explorer-detectable supra-
gingival plaque, regardless of amount.
Alveolar crest height (ACH) was measured in seven
anterior periapical and four posterior vertical bite-
wing radiographs using a single radiographic unit and
cephalometric head positioner according to pro-
cedures developed by Hausmann et al.31 to enhance
accuracy and resolution of ACH measures.25-27
Measurements were conducted on all teeth except
third molars and canines, with two sites measured
per tooth. Using the digitized images, ACH was
measured as the distance in millimeters from the
CEJ to the most coronal part of the alveolar crest in
a plane parallel to the long axis of the tooth. In
a subset of 885 women in the OsteoPerio study, the
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within-examiner coefficient of variation and intra-
class correlation were 5.1% and 0.98 for replicate
measures. Values for interproximal surfaces were
used to calculate worst-site and composite whole-
mouth mean ACH. Extent and severity as described
above were also calculated for ACH.
Periodontal disease status was characterized using
two definitions. The first definition was derived from
the OsteoPerio study27 and was based on ACH and
tooth loss as follows: none (whole-mouth mean ACH
<2 mm; no site ‡4 mm; no reported tooth loss due
to periodontal disease); mild/moderate (whole-mouth
mean ACH ‡2 to <3 mm or ‡1 site ‡4 mm but no
reported tooth loss due to periodontal disease); and
severe (whole-mouth mean ACH ‡3 mm or ‡2 sites
‡5 mm or ‡1 tooth loss due to periodontal disease).
Second, the Centers for Disease Control and Prevention/
American Academy of Periodontology (CDC/AAP)
definition32 based on CAL and PD was used as follows:
none/mild (neither moderate nor severe periodontal
disease); moderate (‡2 interproximal sites with CAL
‡4 mm [not on same tooth] or ‡2 interproximal sites
with PD ‡5 mm [not on same tooth]); and severe
(‡2 interproximal sites with CAL ‡6 mm [not on
same tooth] and ‡1 interproximal site with PD ‡5 mm).
Blood Measures
After overnight fasting and recommended abstinence
from smoking and heavy exertion, venous blood sam-
ples were obtained, processed, portioned to serum
and plasma, and frozen at -80C. The samples as-
sayed for this study had no previous thaw/freeze.
Serum concentrations of glucose and triglyceride
were measured using an enzymatic endpoint col-
orimetric assay,# and serum high-density lipopro-
tein cholesterol (HDL-C) was measured using a
polyanion-polymer complex assay.** Serum insulin
and high-sensitivity C-reactive protein (CRP) were
measured using an electrochemiluminescence im-
munoassay†† and an immunoturbidimetric assay.‡‡
Insulin and CRP were not measured in 37 samples
due to sample volume requirements; thus these two
measures were available in 620 participants (94%).
CRP ‡3 mg/dL was used to define the presence of
systemic inflammation.33 Intra-assay coefficients of
variation were 2.16%, 1.57%, 2.16%, 1.53%, and 1.45%
for glucose, triglyceride, HDL-C, insulin, and CRP,
respectively.
Other Assessments
Body mass index (BMI, kg/m2) was computed from
height and weight measured using a clinical stadi-
ometer and scale. Waist circumference was mea-
sured at the narrowest part of the torso using an
anthropometric tape. After 5 minutes of quiet sit-
ting, resting systolic and diastolic blood pressure
(BP) was measured using auscultatory methods and
an appropriately sized cuff based on measured arm
circumference. The average of two measurements
was recorded for analysis. Questionnaires were
used to obtain information on demographic factors,
personal medical history and medication use, oral
hygiene and dental procedures, cigarette smoking,
physical activity, and dietary intake. Reliability of
clinical measures and self-reported medical and
lifestyle information has been demonstrated among
women enrolled in the WHI-OS.28
MetS Definition
MetS was defined using criteria of the National Cho-
lesterol Education Program,9 requiring the presence
of ‡3 of the following: 1) abdominal obesity (waist
circumference >88 cm); 2) elevated resting BP
(systolic BP ‡135 mmHg or diastolic BP ‡85 mmHg
or use of BP medication); 3) hypertriglyceridemia
(‡150 mg/dL); 4) hyperglycemia (‡100 mg/dL or
use of diabetes medication); and 5) low HDL-C
(<50 mg/dL). Waist circumference was missing in six
participants, so BMI ‡30 kg/m2 was used to define
presence or absence of abdominal obesity in these
individuals. In the cohort, the correlation between
waist circumference and BMI was strong on a con-
tinuous scale (Spearman r = 0.86) and when cross-
classified according to categories of abdominal
(waist >88 cm) and overall (BMI ‡30) obesity (k =
0.59). Although hyperglycemia is one criterion for
MetS, about half of adults with MetS do not have
frank insulin resistance.34,35 Therefore, insulin re-
sistance was also assessed using the homeostasis
model assessment (HOMA) calculated as the product
of fasting insulin (mU/L) and glucose (mmol/L),
divided by 22.5.36 Insulin resistance was categori-
cally defined as HOMA ‡75th percentile (‡2.43 units)
in women without diagnosed diabetes35 and reported
descriptively to further characterize the cohort.
Statistical Analyses
Demographic, health, and lifestyle characteristics and
metabolic and periodontal parameters were com-
pared between those with and without MetS using
x2 tests for proportions and independent t tests or
Wilcoxon rank sum tests of mean differences for
continuous variables. MetS prevalence was exam-
ined across quartiles of PD, CAL, ACH, gingival
bleeding, and plaque using Cochran–Armitage tests
of linear trend. Binary logistic regression was used
to further examine associations between MetS and
periodontal disease measures. Because available
studies have shown MetS to be associated with
more severe16,18,19,22,23 rather than moderate14,15
# Beckman LX20, Beckman, Brea, CA.
** Beckman LX20, Beckman.
†† Roche Modular system, Roche Diagnostics, Mannheim, Germany.
‡‡ Roche Modular system, Roche Diagnostics.
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periodontitis, the periodontal outcome variables for
these analyses were defined as severe periodontitis,
as follows: clinically severe periodontitis defined by
OsteoPerio (ACH-based) or CDC/AAP (PD- and CAL-
based) criteria described earlier; presence of gingival
bleeding at ‡50% of sites measured; and presence
of supragingival plaque at ‡50% of sites measured.
Because of a small amount of missing data on peri-
odontal probing measures, sample sizes varied slightly
for analyses using CAL, gingival bleeding, and plaque
(four missing, n = 653 each) compared with ACH
(none missing, n = 657). Odds ratios (ORs), 95%
confidence intervals (CIs), and two-sided P values
were estimated to measure the strength, precision,
and statistical significance (a = 0.05) of these as-
sociations. Unadjusted, age- and smoking-adjusted,
and multivariable-adjusted associations were esti-
mated. Factors included in multivariable analyses
were based on univariate relationships (P £0.05)
with both MetS and periodontal disease status by
OsteoPerio or CDC/AAP criteria.
RESULTS
MetS prevalence was 25.6% (n = 168) among study
participants. Prevalence of MetS components was
30.1% abdominal obesity, 12.3% hyperglycemia, 36.9%
hypertriglyceridemia, 45.8% elevated BP, and 37.7%
low HDL-C. Women with MetS were, on average, older,
less physically active, and had a higher percentage
of total caloric intake from fat and lower percentage
from carbohydrate compared with women without
MetS (P <0.05 each) (Table 1). The frequency of
reported diagnosis of heart disease and diabetes
was higher, and the frequency of current hormone
therapy use was lower in women with than without
MetS (P <0.05 each). Women with MetS had higher
metabolic risk factor values and higher prevalence
of insulin resistance (HOMA ‡2.43 units) and sys-
temic inflammation (CRP ‡3 mg/dL) compared to
women without MetS (P <0.01 each).
Whole-mouth mean and worst-site ACH, PD, and
CAL were not significantly different between women
with and without MetS (Table 2). Likewise, when
using a ‡4-mm threshold, extent and severity of
ACH, PD, and CAL did not differ between groups.
Women with MetS did, however, have a significantly
greater mean number of sites with gingival bleeding
(P = 0.01) and supragingival plaque (P = 0.004),
and a higher proportion of these women had su-
pragingival plaque at ‡50% of sites measured (P =
0.002) compared with women without MetS. The
mean number of teeth present and the frequency of
reported toothbrushing and dental visits also were
significantly lower in those with than without MetS
(P <0.05 each). Classification into periodontal dis-
ease categories using OsteoPerio or CDC/AAP
criteria was not different according to MetS status.
As seen in Table 3, MetS prevalence did not differ
across quartiles of worst-site or whole-mouth mean
ACH, CAL, or PD but was significantly higher across
incremental quartiles of gingival bleeding (trend: P =
0.02) and supragingival plaque (trend: P = 0.008).
Next, logistic regression analysis was used to ex-
amine associations between MetS presence and mea-
sures of severe periodontitis (Table 4). In unadjusted
analyses, MetS was significantly associated with su-
pragingival plaque (OR = 1.74; 95% CI: 1.22 to 2.50;
P = 0.002) and non-significantly associated with
ACH (OR = 1.23; 95% CI: 0.81, 1.85; P = 0.34) and
gingival bleeding (OR = 1.20; 95% CI: 0.81 to 1.77;
P = 0.36). Adjustment for age and smoking at-
tenuated these associations; however, supragingival
plaque remained significantly associated with MetS
(OR = 1.63; 95% CI: 1.13 to 2.35; P = 0.008).
Additional adjustment for hormone therapy use,
history of diagnosed heart disease, toothbrushing and
dental visits, physical activity, and percent caloric
intake from fat further attenuated associations, though
supragingival plaque remained statistically signifi-
cant (OR = 1.47; 95% CI: 1.00 to 2.16; P = 0.049).
Because the presence of gingival plaque could
coexist with heightened inflammation as part of an
altered host response to gingival insult,13,37 an ex-
ploratory analysis was conducted stratifying the as-
sociation according to serum CRP values of <3 and
‡3 mg/dL and inspecting for changes in the mag-
nitude of point and interval estimates to guide
interpretation of this analysis. The multivariable as-
sociation between MetS and supragingival plaque
was strengthened in women with high serum CRP
(n = 240; 79 MetS cases, 52 plaque cases; OR = 2.04;
95% CI: 1.12 to 3.74; P = 0.02) and attenuated
in those with lower CRP (n = 380; 78 MetS cases,
42 plaque cases; OR = 1.07; 95% CI: 0.62 to 1.84;
P = 0.82).
The authors also examined associations between
each MetS component and the periodontal mea-
sures (Table 5). Abdominal obesity tended to carry
associations of moderate strength (ORs of 1.24 to
1.54), whereas associations for other components
were variable. The strongest associations tended to
be with supragingival plaque.
Sensitivity analyses were conducted to explore
the role that diagnosed diabetes and oral hygiene
may have in the observed associations. After ex-
cluding women with diagnosed treated diabetes
mellitus (n = 24), multivariable results (data not
shown) were materially the same as those shown in
Table 4, suggesting that existing diabetes had little
impact on the observed associations, likely due to
its relatively low prevalence in the cohort. Multi-
variable analyses including all covariables except
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Table 1.
Participant Characteristics for All Women and According to MetS Status
MetS
Characteristic All Women Absent Present P
n 657 489 (74.4) 168 (25.6)
Age at visit (years) 65.5 – 6.6 65.1 – 6.6 66.6 – 6.7 0.02
<60 147 (22.3) 120 (24.5) 27 (16.0) 0.06
60 to 69 321 (48.8) 235 (48.0) 86 (51.1)
‡70 189 (28.7) 134 (27.4) 55 (32.7)
White 649 (98.7) 483 (98.7) 166 (98.9) 0.97
College education or graduate school 518 (80.0) 389 (80.7) 129 (78.1) 0.18
Cigarette smoking 0.68
Never 360 (54.7) 269 (55.0) 91 (54.1)
Former 283 (43.0) 211 (43.1) 72 (42.8)
Current 14 (2.1) 9 (1.8) 5 (2.9)
Hormone therapy use <0.001
Never 197 (29.9) 129 (26.3) 68 (40.4)
Former 125 (19.0) 90 (18.4) 35 (20.8)
Current 335 (50.9) 270 (55.2) 65 (38.6)
History of diagnosed heart disease 56 (8.5) 35 (7.1) 21 (12.5) 0.03
History of diagnosed diabetes 24 (3.6) 6 (1.2) 18 (10.7) <0.001
History of diagnosed hypertension 216 (32.9) 115 (23.5) 101 (60.1) <0.001
Age at menopause (years) 48.1 – 5.3 48.1 – 5.0 47.8 – 6.4 0.58
Recreational physical activity (MET-hours/week) 14.5 – 14.6 16.1 – 15.1 9.8 – 11.8 <0.001
Total caloric intake (kcal/day) 1,548 – 526 1,530 – 519 1,600 – 543 0.14
Percent of total calories from fat 31.0 – 8.5 30.2 – 8.4 33.3 – 7.9 <0.001
Percent of total calories from carbohydrates 51.3 – 9.7 51.8 – 9.8 49.8 – 9.5 0.02
BMI (kg/m2) 26.4 – 4.9 25.1 – 3.9 30.3 – 5.4 <0.001
Waist circumference (cm) 83.9 – 11.9 80.4 – 9.6 94.1 – 12.1 <0.001
Glucose (mg/dL), median (IQR) 85.0 (13.0) 84.0 (11.0) 94.0 (27.5) <0.001
Triglyceride (mg/dL), median (IQR) 127.0 (89.0) 109.0 (60.0) 199.5 (92.0) <0.001
HDL cholesterol (mg/dL) 54.6 – 15.0 58.6 – 14.5 43.1 – 9.4 <0.001
Systolic BP (mmHg) 121.4 – 18.0 118.6 – 17.2 129.7 – 17.8 <0.001
Diastolic BP (mmHg) 70.9 – 8.8 70.3 – 8.7 72.6 – 9.1 0.005
Insulin (mU/L), median (IQR) 6.4 (7.2) 5.5 (4.1) 13.3 (12.1) <0.001
HOMA (units), median (IQR)* 1.3 (1.6) 1.1 (0.9) 3.1 (3.5) <0.001
Insulin resistance† 168 (27.0) 69 (14.9) 99 (63.0) <0.001
CRP (mg/L), median (IQR)* 2.2 (3.2) 1.9 (3.1) 3.0 (3.5) <0.001
High CRP (‡3 mg/dL) 240 (38.7) 162 (34.9) 79 (50.3) <0.001
IQR = interquartile range; MET = metabolic equivalent of task.
Data given as mean – SD or n (%) unless otherwise noted.
* Total n = 620.
† Defined as HOMA value ‡75th percentile (‡2.43 units) among women without diabetes.
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Table 2.
Periodontal Measures for all Women and According to MetS Status
MetS
Characteristic All Women Absent Present P
n 657 489 (74.4) 168 (25.6)
ACH (mm)
Worst-site 0.29
Mean – SD 4.4 – 1.5 4.4 – 1.4 4.6 – 1.7
Range 2.0 to 12.6 2.0 to 11.5 2.0 to 12.6
Whole-mouth mean 0.40
Mean – SD 2.3 – 0.7 2.3 – 0.6 2.4 – 0.8
Range 1.0 to 8.9 1.0 to 6.4 1.2 to 8.9
Whole-mouth mean ‡4 mm at ‡1 site
Extent (%)* 0.53
Mean – SD 7.3 – 13.3 7.1 – 13.0 7.8 – 14.0
Range 0 to 100 0 to 100 0 to 100
Severity (mm)† 0.65
Mean – SD 4.7 – 0.6 4.7 – 0.5 4.7 – 0.7
Range 4.0 to 8.9 4.0 to 7.1 4.0 to 8.9
CAL (mm)
Worst-site 0.29
Mean – SD 5.7 – 1.7 5.6 – 1.6 5.8 – 1.8
Range 2.8 to 13.8 2.8 to 13.8 3.0 to 12.6
Whole-mouth mean 0.57
Mean – SD 2.4 – 0.6 2.4 – 0.6 2.4 – 0.6
Range 1.1 to 7.3 1.2 to 5.1 1.1 to 7.3
Whole-mouth mean ‡4 mm at ‡1 site
Extent (%)* 0.26
Mean – SD 10.6 – 13.2 10.3 – 12.9 11.6 – 14.0
Range 0 to 100 0 to 81.8 0 to 100
Severity (mm)† 0.17
Mean – SD 4.7 – 0.5 4.7 – 0.5 4.7 – 0.5
Range 4.0 to 9.3 4.0 to 7.3 4.0 to 9.3
PD (mm)
Worst-site 0.72
Mean – SD 4.9 – 1.2 4.8 – 1.2 4.9 – 1.3
Range 2.4 to 10.8 2.4 to 10.8 2.8 to 9.8
Whole-mouth mean 0.94
Mean – SD 2.2 – 0.3 2.2 – 0.3 2.2 – 0.4
Range 1.4 to 4.0 1.4 to 4.0 1.5 to 3.7
Whole-mouth mean ‡4 mm at ‡1 site
Extent (%)* 0.32
Mean – SD 4.9 – 6.4 4.8 – 6.2 5.4 – 6.9
Range 0 to 49.0 0 to 49.0 0 to 35.7
Severity (mm)† 0.40
Mean – SD 4.5 – 0.4 4.5 – 0.4 4.5 – 0.4
Range 4.0 to 7.2 4.0 to 7.2 4.0 to 7.0
Gingival bleeding, n sites 0.3 – 0.2 0.3 – 0.2 0.4 – 0.2 0.01
‡50% of sites 175 (26.8) 126 (25.8) 49 (29.5) 0.36
PI, n sites 0.5 – 0.2 0.1 – 0.2 0.5 – 0.2 0.004
‡50% of sites 335 (51.2) 233 (47.7) 102 (61.2) 0.002
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for toothbrushing and dental visits (data not shown)
were comparable to those in Tables 4 and 5, sug-
gesting that controlling for oral hygiene did not
overadjust the associations in the cohort.
DISCUSSION
Menopausal hormone changes give rise to metabolic
abnormalities predisposing postmenopausal women
to MetS and periodontitis.12,13 The present cross-
sectional study in ambulatory postmenopausal women
indicates that MetS was significantly and positively
associated with presence of supragingival plaque.
The association persisted after adjustment for age,
smoking, hormone therapy use, history of diagnosed
heart disease, oral hygiene, and lifestyle habits and
was somewhat stronger in women with elevated serum
CRP, a marker of systemic inflammation. MetS tended
to be positively associated with measures of severe
periodontitis defined by ACH and gingival bleeding;
however, these associations did not reach statistical
significance and were substantially attenuated in
multivariable analyses. With the exception of ab-
dominal obesity, associations between MetS com-
ponents and periodontitis were less consistent and
generally not statistically significant. MetS was not
associated with CAL and PD measures of peri-
odontitis, including when using CDC/AAP criteria.
To the authors’ knowledge, this is the most com-
prehensive evaluation of MetS and periodontitis and
the only study focused on older postmenopausal
women. Study strengths include the well-characterized
cohort of postmenopausal women, availability of
several periodontal measures (including ACH from
oral radiographs and gingival measures from probing
procedures), availability of measured phenotypes to
define MetS using standard clinical criteria, and
availability of information on relevant covariables
for consideration in multivariable analyses. Given
the projected doubling of older U.S. adults in the
coming decades38 and the associated burden of
periodontal disease,1,3 an association with MetS could
have implications for improved control of periodontal
disease and shared clinical complications.
One other study has been published on the as-
sociation between MetS and supragingival plaque.
Li et al.20 examined 208 adults (mean age: 60 years
[59% women]), and after adjustment for age, sex,
and smoking, showed that MetS was significantly
associated with whole-mouth supragingival plaque
index (PI). The present findings generally were in
agreement with those of Li et al. A significant trend
was observed for higher prevalence of MetS across
incremental quartiles of supragingival plaque and,
after adjustment for age and smoking, 67% higher
relative odds of having severe supragingival plaque
were observed in women with MetS. After further
adjustments, the multivariable odds of supragingival
plaque remained 47% higher in women with MetS in
the overall cohort and two-fold higher in the subset
of women with evidence of systemic inflammation
Table 2. (continued)
Periodontal Measures for all Women and According to MetS Status
MetS
Characteristic All Women Absent Present P
Teeth present, n 23.8 – 4.8 24.2 – 4.4 22.6 – 5.7 0.001
Tooth loss to periodontitis, n 0.4 – 2.2 0.4 – 2.2 0.3 – 1.9 0.65
Toothbrushing ‡2 times per day 503 (76.5) 387 (79.1) 116 (69.0) 0.007
Floss teeth daily 281 (42.8) 213 (43.6) 68 (40.4) 0.72
Dental visit ‡1 time per year 607 (92.4) 458 (93.6) 149 (88.6) 0.047
Periodontal disease status
OsteoPerio definition27 0.55
None 180 (27.4) 133 (27.2) 47 (27.9)
Mild/moderate 334 (50.8) 254 (51.9) 80 (47.6)
Severe 143 (21.7) 102 (20.8) 41 (24.4)
CDC/AAP definition32 0.76
None/mild 147 (22.5) 107 (21.9) 40 (23.1)
Moderate 401 (61.0) 303 (62.2) 98 (59.0)
Severe 105 (16.0) 77 (15.8) 28 (16.8)
Data given as mean – SD or n (%).
* Percent of total sites with ‡4 mm in ACH, CAL, or PD.
† Mean ACH, CAL, or PD at sites with ‡4 mm.
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by CRP. The proportion of women reporting tooth-
brushing at least twice a day and dental visits at least
once a year was significantly lower in women with
than without MetS. The lower frequency of tooth-
brushing could increase plaque in MetS, as could
seeing a dentist less frequently. MetS is associated
with chronic inflammation,9 and periodontitis is a
chronic inflammatory disease13 emanating from gin-
gival insult by polymicrobial dental plaque,37 which
could account for a somewhat stronger association
in women with evidence of systemic inflammation.
The association between MetS and ACH has been
reported by one other study. Nesbitt et al.22 used
whole-mouth radiographs to define severe peri-
odontitis as ACH ‡3 mm in 200 adults (mean age:
56 years, 42% women) and, after adjusting for age,
sex, and smoking, showed an OR of 2.61 (P <0.05)
for severe periodontitis in those with MetS. Although
in the present study MetS is associated with a non-
significant 14% higher age- and smoking-adjusted
relative odds of severe periodontitis defined by ACH,
mean values of whole-mouth and worst-site ACH,
and the extent and severity of ACH (4-mm thresh-
old), did not differ by MetS status.
One other study has reported findings on the
association between MetS and gingival bleeding.
Table 3.
Prevalence of MetS Across Quartiles of Periodontal Disease Measures
Periodontal Quartile
Characteristic 1 (low) 2 3 4 (high) P, trend*
Worst-site ACH
Median (mm) 3.1 3.8 4.5 6.0
Metabolic syndrome, n 42 43 39 44 0.91
% (SE) 25.4 (3.3) 26.2 (3.4) 23.7 (3.3) 26.8 (3.4)
Whole-mouth mean ACH
Median (mm) 1.6 2.0 2.4 3.0
MetS, n 42 36 46 44 0.50
% (SE) 25.3 (3.3) 22.0 (3.2) 28.2 (3.5) 26.6 (3.4)
Worst-site CAL
Median (mm) 4.0 4.8 5.8 7.6
MetS, n 44 31 42 49 0.37
% (SE) 24.8 (3.2) 21.9 (3.4) 26.0 (3.4) 28.1 (3.4)
Whole-mouth mean CAL
Median (mm) 1.8 2.1 2.4 3.0
MetS, n 41 40 35 50 0.37
% (SE) 25.3 (3.4) 24.2 (3.3) 21.3 (3.2) 30.8 (3.6)
Worst-site PD
Median (mm) 3.6 4.4 5.0 6.2
MetS, n 34 52 42 39 0.93
% (SE) 22.8 (3.4) 27.3 (3.2) 30.0 (3.8) 22.2 (3.1)
Whole-mouth mean PD
Median (mm) 1.8 2.0 2.3 2.6
MetS, n 42 51 32 42 0.46
% (SE) 25.7 (3.4) 30.5 (3.5) 20.1 (3.1) 25.4 (3.3)
Gingival bleeding
Median 0.1 0.2 0.4 0.6
MetS, n 31 38 53 44 0.02
% (SE) 18.9 (3.0) 23.6 (3.3) 31.3 (3.5) 27.6 (3.5)
PI
Median 0.2 0.4 0.6 0.8
MetS, n 32 34 52 48 0.008
% (SE) 19.3 (3.0) 20.9 (3.2) 32.1 (3.6) 29.0 (3.5)
* Cochran–Armitage test.
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D’Aiuto et al.15 reported a multivariable-adjusted
OR of 1.12 (P <0.05) associated with each 10% in-
crement in percentage bleeding sites among 13,677
adults (‡17 years old, 51% women) in the U.S.
National Health and Nutrition Examination Survey
(1988 to 1994). Significantly more mean sites with
bleeding were observed in women with MetS, and
significantly higher MetS prevalence was observed
across incremental quartiles of gingival bleeding. After
adjusting for age and smoking, a non-significant 17%
higher relative odds of severe gingival bleeding was
associated with MetS, but further adjustment weak-
ened this relationship.
Contrary to these results, several studies have shown
statistically significant positive associations between
MetS and measures of CAL and PD16-21,23,24 including
CDC/AAP criteria.15 Among older adults, multivariable-
adjusted ORs have been 1.74 for severe periodontitis
by CDC/AAP criteria15 to as high as 6.0 for PD ‡4
mm.18 Little difference was found in mean CAL and
PD, extent and severity of CAL and PD (4-mm
threshold), or CDC/AAP disease classification when
comparing MetS groups, and prevalence of MetS
did not differ according to quartiles of CAL or PD.
It is not clear why these findings for CAL and PD
are inconsistent with those of other published studies.
Potential explanations involve differences in case defi-
nitions or prevalence of MetS and periodontitis. As in
this study, most published studies14-19,21-23 defined
MetS using National Cholesterol Education Panel-
Adult Treatment Panel III criteria or slight modifi-
cations thereof. MetS prevalence has ranged from
as low as 8%21 to as high as 28%,14 with a majority
of studies reporting 15%.16,22-24 In the present study,
MetS prevalence was 25%, which is within the range
reported in previous studies showing positive as-
sociations between MetS and periodontitis.16,19,22-24
Prevalence of MetS components also was comparable
with previous studies on periodontal disease,14,19,23
including prevalence of hyperglycemia and ab-
dominal obesity, which are known periodontal risk
factors.6,39 Although MetS prevalence in the present
study on older postmenopausal women is comparable
to that in previous periodontal studies and in the
WHI study,40,41 prevalence is curiously lower than
expected in women of similar age nationally.11 Even
so, insufficient MetS prevalence does not likely explain
the lack of stronger findings in the present study.
Table 4.
ORs and 95% CIs for Periodontal Disease According to MetS Status
MetS
Periodontal Disease Outcome Absent Present P
n 489 168
Severe periodontitis by ACH (OsteoPerio definition27)
Cases, n (%) 102 (20.8) 41 (24.4)
Unadjusted 1.00 (referent) 1.23 (0.81 to 1.85) 0.34
Age- and smoking-adjusted 1.00 (referent) 1.14 (0.74 to 1.74) 0.55
Multivariable-adjusted* 1.00 (referent) 1.11 (0.71 to 1.75) 0.64
Severe periodontitis by CAL, PD (CDC-AAP definition32)
Cases, n (%) 77 (15.8) 28 (16.8)
Unadjusted 1.00 (referent) 1.08 (0.67 to 1.74) 0.75
Age- and smoking-adjusted 1.00 (referent) 1.07 (0.67 to 1.73) 0.77
Multivariable-adjusted* 1.00 (referent) 1.02 (0.62 to 1.68) 0.93
Gingival bleeding ‡50% of sites
Cases, n (%) 126 (25.8) 49 (29.5)
Unadjusted 1.00 (referent) 1.20 (0.81 to 1.77) 0.36
Age- and smoking-adjusted 1.00 (referent) 1.17 (0.79 to 1.73) 0.44
Multivariable-adjusted* 1.00 (referent) 1.06 (0.70 to 1.61) 0.78
PI ‡50% of sites
Cases, n (%) 233 (47.7) 102 (61.4)
Unadjusted 1.00 (referent) 1.74 (1.22 to 2.50) 0.002
Age- and smoking-adjusted 1.00 (referent) 1.63 (1.13 to 2.35) 0.008
Multivariable-adjusted* 1.00 (referent) 1.47 (1.00 to 2.16) 0.049
* Adjusted for age (years), smoking (never, ever), hormone therapy use (never, former, current), history of diagnosed heart disease (yes, no), toothbrushing
(<2 times/day, ‡2 times/day), dental visits (never or only with problem, ‡1 time/year), recreational physical activity (metabolic equivalent of task [MET]-
hours/week), and percent daily caloric intake from fat.
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Availability of several periodontal measures al-
lowed for examination of periodontitis case defini-
tions of comparable severity and prevalence as
reported in previous investigations on MetS. The
threshold of 4 mm for defining extent and severity
of CAL and PD is similar to thresholds used by
others for CAL16,20,23 and PD,16-19,21,24 as is clas-
sification by CDC/AAP criteria.14,15 Likewise, the
thresholds for ACH-defined periodontitis is com-
parable to the threshold and prevalence reported by
Nesbitt et al.22 Periodontal measures were from whole-
mouth examinations as in most14,16,19,20,22,24 but
not all15,18,21,23 previous studies. It is unlikely that
differences in the nature of oral examinations or the
severity or prevalence of periodontal disease explain
the discordance between the present and previous
study findings.
Smoking is a strong determinant of periodontal
disease presence and severity3,8,27 and is correlated
with MetS presence.11 Prevalence of current smoking
was only 2% in the present cohort of older women,
lower than reported in most studies on MetS and
periodontitis. Significant positive associations be-
tween MetS and periodontitis have been reported in
analyses restricted to non-smokers.15,20,21,24 Dif-
ferences in prevalence of current smokers likely
does not fully account for the disparate findings.
Not all published studies have shown an asso-
ciation between MetS and periodontitis,14 particu-
larly when restricted to women.17,18,21 Benguigui
et al.14 showed in 255 adults after adjustments for
age, sex, and smoking that MetS was not signifi-
cantly associated with periodontitis defined by
CDC/AAP criteria. In that relatively small study, the
criteria and prevalence of MetS and periodontitis
were comparable to the present study. In three other
studies,17,18,21 when analyses were restricted to women
(n 500), associations between MetS and peri-
odontitis were attenuated and no longer significant.
However, significant associations have been reported
specifically in women.16,19
The reasons for inconsistent findings in women
are unclear. The authors hypothesized that hormonal
and metabolic changes with menopause contribute
to both systemic and local inflammation as the basis
for observing a relationship between MetS and mea-
sures of severe periodontitis in older postmenopausal
women. Indeed, an association was observed with
supragingival plaque and gingival bleeding, which
are related to local inflammation. The association
with plaque was strengthened in the presence of
elevated CRP, a marker of systemic inflammation.
Findings were less consistent with other periodontal
measures. As speculated by others,19,20 MetS could
be most influential on acute inflammatory stages of
periodontal disease, such as plaque accretion and
gingivitis, and less so in more chronic stages of dis-
ease such as alveolar bone loss. Although the present
findings align somewhat with this supposition, the
authors also would have expected stronger and more
consistent relationships with PD. Factors known to
be related with inflammation and periodontitis, such
as hormone therapy use, diagnosed heart disease,
and health behaviors, differed between women with
and without MetS. Although statistical procedures
were used to control for the influence of these var-
iables, it is possible that residual effects remained.
Limitations of the present study include the cross-
sectional design, which precludes causal inference.
Statistical power to detect small associations may
have been limited by sample size. The cohort is
largely white and college educated; however, there
are no published data showing that association
between MetS and periodontitis differs according to
race/ethnicity or education status. Although par-
ticipants were required to have ‡6 teeth for study
enrollment and oral hygiene was quite good, the
prevalence of severe periodontitis was similar to
that in other studies on MetS. These study charac-
teristics need be considered when generalizing these
findings to other groups.
CONCLUSIONS
In conclusion, MetS was not consistently associated
with periodontal measures in this cohort of ambu-
latory community-dwelling older postmenopausal
women. Measures of gingival plaque and inflam-
mation were associated overall and by abdominal
obesity. Further investigation is required to clarify
these findings.
ACKNOWLEDGMENTS
This study was supported by the following funding
sources: National Heart, Lung, and Blood Institute
contract N01WH32122; National Institute for Dental
and Craniofacial Research Grants: DE13505, DE04898,
and DE022654; and U.S. Army Reserve Medical
Corps Grant: DAMD17-96-1-6319. The authors re-
port no conflicts of interest related to this study.
REFERENCES
1. Griffin SO, Jones JA, BrunsonD,Griffin PM, BaileyWD.
Burden of oral disease among older adults and impli-
cations for public health priorities. Am J Public Health
2012;1023:411-418.
2. Petersen PE, Yamamoto T. Improving the oral health of
older people: The approach of the WHO Global Oral
Health Programme. Community Dent Oral Epidemiol
2005;33:81-92.
3. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco
RJ; CDC Periodontal Disease Surveillance work-
group. Prevalence of periodontitis in adults in the
United States: 2009 and 2010. J Dent Res 2012;91:
914-920.
J Periodontol • November 2014 LaMonte, Williams, Genco, et al.
1499
4. Al-Zahrani MS, Bissada NF, Borawski EA. Poor overall
diet quality as a potential risk factor for periodontitis.
J Periodontol 2003;74:1402 (Abstr.).
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